Epion Study Associates Keratoconus Severity and Age with ECD Decline

Keratoconus severity correlates with cell density decline

Corneal endothelial cell density (ECD) drops as keratoconus advances and patients age, according to a new peer-reviewed study, Eyewire+ reported.

The research, published in the journal Cornea, analyzed baseline data from 477 eyes across 11 clinical sites. While the study found a clear connection between disease progression and declining cell counts, the density remained within physiological limits for nearly every patient involved.

The findings represent the first peer-reviewed publication stemming from Epion Therapeutics’ Phase 3 clinical program. While the data were gathered during trials for EpiSmart—an epithelium-on corneal cross-linking treatment—the published results focus specifically on baseline endothelial characteristics rather than the efficacy or safety of the treatment itself.

Baseline endothelial data from Phase 3 trials

Investigators collaborated with the Corneal Image Analysis Reading Center (CIARC) at the UH Eye Institute in Cleveland to conduct the analysis. They utilized specular microscopy and corneal tomography to examine how central ECD relates to specific indicators of keratoconus, such as corneal thickness, curvature, and elevation.

The study tracked 254 patients to establish these baseline metrics. The data revealed a statistically significant reduction in cell density as both the severity of the condition and the age of the patient increased.

Despite this downward trend, the health of the corneal endothelium appeared remarkably resilient in the study population. The researchers noted that endothelial cell counts stayed within normal physiological ranges in almost all eyes, even those categorized with advanced keratoconus.

Endothelial cell density metrics

Metric Category	Value/Observation
Mean baseline ECD	2,802 ± 285 cells/mm²
Eyes below 2,000 cells/mm²	1
Total eyes analyzed	477

Clinical implications for keratoconus management

Understanding the relationship between cell density and disease progression is vital for clinicians managing keratoconus. Because the endothelium maintains corneal hydration, a drop in cell density can lead to corneal swelling and vision loss.

For patients, these findings offer a nuanced perspective on disease progression. The data suggests that while the disease may impact cell counts, the biological reserve of the cornea often remains sufficient to maintain function, even in advanced stages.

This baseline data provides a critical benchmark for future evaluations of the EpiSmart treatment. By establishing exactly what the corneal environment looks like before intervention, researchers can better interpret how subsequent treatments might influence or preserve these vital cell populations.

The study can be found via PubMed, documenting the specific associations found between central ECD and corneal topography.

The publication of these baseline characteristics marks a formal step in the transparency of the Phase 3 program, providing a scientific foundation for the broader clinical evaluations currently underway.

Keep reading